Toll Free: 1-888-928-9744

Pre-Eclampsia Global Clinical Trials Review, H1, 2016

Published: Apr 15, 2016 | Pages: 129 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Pre-Eclampsia Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Pre-Eclampsia Global Clinical Trials Review, H1, 2016" provides an overview of Pre-Eclampsia clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials 17 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Pre-Eclampsia Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Pre-Eclampsia 31 Jan 14, 2016: St. John Hospital Enrolling Patients in Phase 3 Trial for Early Onset Preeclampsia 31 Clinical Trial Profile Snapshots 32 Appendix 126 Abbreviations 126 Definitions 126 Research Methodology 127 Secondary Research 127 About GlobalData 128 Contact Us 128 Disclaimer 128 Source 129
List of Tables
Pre-Eclampsia Therapeutics, Global, Clinical Trials by Region, 2016* 6 Pre-Eclampsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Pre-Eclampsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Pre-Eclampsia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Pre-Eclampsia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Pre-Eclampsia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 Pre-Eclampsia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13 Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14 Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Pre-Eclampsia Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Pre-Eclampsia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Pre-Eclampsia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Pre-Eclampsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Pre-Eclampsia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Pre-Eclampsia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Pre-Eclampsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Pre-Eclampsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Pre-Eclampsia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Pre-Eclampsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Pre-Eclampsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Pre-Eclampsia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Pre-Eclampsia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Pre-Eclampsia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 Pre-Eclampsia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13 Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14 Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 17 Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Pre-Eclampsia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Pre-Eclampsia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Pre-Eclampsia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Pre-Eclampsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Pre-Eclampsia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Pre-Eclampsia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Pre-Eclampsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Pre-Eclampsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 127

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to dri

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...

Global PP (Polypropylene) nonwoven fabric market size is anticipated to be valued at USD 30.6 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing usage of hygiene products such as incontinence products and baby diapers is

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify